Animal Antimicrobials and Antibiotics Market worth $4,143.8 Million by 2018

Monday 12 May 2014, Amsterdam

The “Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018”, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and the Rest of the World (RoW).

This report studies the global animal antimicrobials and antibiotics market, with forecast to 2018.

The animal antimicrobials and antibiotics market has experienced sluggish growth in the past few years, mainly due to the dearth of antibiotics in the pipeline of pharmaceutical companies, regulatory authorities of various nations banning the use of antibiotics, and increasing concerns about antibiotic resistances. Factors that are expected to propel the market growth include rise in demand for animal protein products, along with an increase in the trend of companion animal ownership especially in the emerging countries. However, the regulatory ban posed by United States Food and Drug Administration (FDA) on the use of antibiotics, increased usage of in-feed enzymes, competitive exclusion products and probiotics as an alternative to antibiotics and prophylactic use of antibiotics being replaced by good husbandry, environment and hygienic practices are factors that inhibit the growth of the market to a certain extent.

In this report, the global animal antimicrobials and antibiotics market is segmented by product type, animals, mode of delivery, geography, and country. It also discusses the key market drivers, restraints, and opportunities of this market and its sub-markets. The market was valued at $3,340.8 million in 2013 and is expected to grow at a modest CAGR of 4.4% from 2013 to 2018.

North America was major market for global animal antimicrobials and antibiotics with a market share of around 28% to 30% of the global market, closely followed by Europe. Both of these regions namely, North America and Europe are experiencing sluggish growth in the animals antimicrobials and antibiotics market. Regulatory ban on usage of antibiotics, growing antibiotic resistance, dearth of new antibiotics in pharmaceutical companies pipeline are major factors curbing the growth of these markets.

The major players in the animal antimicrobials and antibiotics market are Zoetis Inc. (U.S.), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Merial (U.S.), Bayer Animal Health (Germany), Virbac Animal Health (U.S.),  and CEVA Santé Animale (U.S.)., among others, among others.